Drugs / Pyrantel Pamoate
last change Jun 2022 re-read 2 minutes ago

Pyrantel Pamoate

Developed for
hookworm infectious disease
Investigated by
Swiss Tropical & Public Health Institute

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03278431 Sep → Nov 2017 hookworm infectious disease Swiss Tropical & Public Health Institute Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT02812615 Background Jul 2016 → Jun 2022 infectious disease, protein-energy malnutrition International Centre for Diarrhoeal Disease Research, Bangladesh Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Pyrantel Pamoate ClinicalTrials.gov intervention name — accepted as the source's own label NCT02812615
1

NCT03278431